Richard G Vile (Richard Vile)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 9

Top Venues

Nature communications

Research square

Cancer immunology research

Journal for immunotherapy of cancer

Mayo Clinic

Institute for Cancer Research (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Mayo Clinic

United States

Molecular Medicine :: Molecular Medicine

Education History

Institute for Cancer Research

United Kingdom

PHD

Publications

Mason James Webb, Thanich Sangsuwannukul, Jacob van Vloten, Laura Evgin, Benjamin Kendall, Jason Tonne, Jill Thompson, Muriel Metko, Madelyn Moore, Maria P Chiriboga Yerovi, Michael Olin, Antonella Borgatti, Mark McNiven, Satdarshan Paul Monga, Mitesh J Borad, Alan A Melcher, Lewis Rowland Roberts, Richard G Vile
Expression of tumor antigens within an oncolytic virus enhances the anti-tumor T cell response. Nature communications 15 (1) (2024)
Mason James Webb, Thanich Sangsuwannukul, Jacob van Vloten, Laura Evgin, Benjamin Kendall, Jason Tonne, Jill Thompson, Muriel Metko, Madelyn Moore, Maria P Chiriboga Yerovi, Michael Olin, Antonella Borgatti, Mark McNiven, Satdarshan Paul Monga, Mitesh J Borad, Alan A Melcher, Lewis Rowland Roberts, Richard G Vile
Expression of tumor antigens within an oncolytic virus enhances the anti-tumor T cell response. Nature communications 15 (1) (2024)
Mason James Webb, Thanich Sangsuwannukul, Jacob van Vloten, Laura Evgin, Benjamin Kendall, Jason Tonne, Jill Thompson, Muriel Metko, Madelyn Moore, Maria P Chiriboga Yerovi, Michael Olin, Antonella Borgatti, Mark McNiven, Satdarshan Paul Monga, Mitesh J Borad, Alan A Melcher, Lewis Rowland Roberts, Richard G Vile
Expression of tumor antigens within an oncolytic virus enhances the anti-tumor T cell response. Nature communications 15 (1) (2024)
Mason James Webb, Thanich Sangsuwannukul, Jacob van Vloten, Laura Evgin, Benjamin Kendall, Jason Tonne, Jill Thompson, Muriel Metko, Madelyn Moore, Maria P Chiriboga Yerovi, Michael Olin, Antonella Borgatti, Mark McNiven, Satdarshan Paul Monga, Mitesh J Borad, Alan A Melcher, Lewis Rowland Roberts, Richard G Vile
Expression of tumor antigens within an oncolytic virus enhances the anti-tumor T cell response. Nature communications 15 (1) (2024)
Zachariah P Tritz, Katayoun Ayasoufi, Delaney M Wolf, Carley A Owens, Courtney S Malo, Benjamin T Himes, Cori E Fain, Emma N Goddery, Lila T Witt, Fang Jin, Michael J Hansen, Ian F Parney, Chensu Wang, Kelly D Moynihan, Darrell J Irvine, Karl Dane Wittrup, Rosa M Diaz Marcano, Richard G Vile, Aaron J Johnson
Anti-PD-1 and extended half-life-IL-2 synergize for treatment of murine glioblastoma independent of host MHC Class I expression. Cancer immunology research (2023)
Richard G Vile, Mason James Webb, Jacob van Vloten, Laura Evgin, Thanich Sangsuwannukul, Benjamin Kendall, Jason Tonne, Jill Thompson, Muriel Metko, Madelyn Moore, Maria Chiriboga Yerovi, Mark McNiven, Satdarshan Paul Monga, Mitesh Borad, Lewis Rowland Roberts
Chimerization of the Anti-Viral CD8+ T Cell Response with A Broad Anti-Tumor T Cell Response Reverses Inhibition of Checkpoint Blockade Therapy by Oncolytic Virotherapy. Research square (2023)
Timothy Kottke, Jason Tonne, Laura Evgin, Christopher B Driscoll, Jacob P van Vloten, Victoria A Jennings, Amanda L Huff, Brady Zell, Jill M Thompson, Phonphimon Wongthida, Jose Pulido, Matthew R Schuelke, Adel Samson, Peter Selby, Elizabeth J Ilett, Mark McNiven, Lewis Rowland Roberts, Mitesh J Borad, Hardev Pandha, Kevin J Harrington, Alan Melcher, Richard G Vile
Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy. Nature communications 12 (1) (2021)
Laura Evgin, Amanda L Huff, Phonphimon Wongthida, Jill Thompson, Tim Kottke, Jason Tonne, Matthew R Schuelke, Katayoun Ayasoufi, Christopher B Driscoll, Kevin G Shim, Pierce Reynolds, Dileep D Monie, Aaron J Johnson, Matt Coffey, Sarah L Young, Gary Archer, John Sampson, Jose Pulido, Luis Sanchez Perez, Richard G Vile
Oncolytic virus-derived type I interferon restricts CAR T cell therapy. Nature communications 11 (1) (2020)
Matthew R Schuelke, Phonphimon Wongthida, Jill Thompson, Timothy Kottke, Christopher B Driscoll, Amanda L Huff, Kevin G Shim, Matt Coffey, Jose Pulido, Laura Evgin, Richard G Vile
Diverse immunotherapies can effectively treat syngeneic brainstem tumors in the absence of overt toxicity. Journal for immunotherapy of cancer 7 (1) (2019)

Richard G Vile.css-eqlu8i{font-size:small;padding-left:4px;} (Richard Vile)

Publication Activity (10 Years)

Top Topics

Top Venues

Richard G Vile (Richard Vile)